PERIsign has successfully passed the first stage of the European Innovation Council (EIC) Accelerator application process and has been invited to submit a full Step 2 proposal.
This is an encouraging recognition of PERIsign’s potential to bring objective information to the assessment of patients with acute abdominal pain. Our ambition is to support physicians in the emergency department and contribute to more efficient care.
We are now preparing our Step 2 application for submission this autumn, outlining plans for further product development, clinical validation and market introduction. EIC funding would accelerate these activities and bring PERIsign closer to clinical practice.